Reduced GLP-1 levels are directly associated with development of metabolic disorders, including type 2 diabetes and obesity
Indications and eGFR thresholds may vary by region
Vivek Lal to improve respiratory structure and function, support gut health and better sleep
In a study (New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes) published on February 12, 2026, participants who started taking semaglutide were about 2 times more likely to develop NAION than participants who took sodium-glucose cotransporter-2 inhibitors
2 Due to these benefits, this class of medications is currently being investigated in clinical trials for Alzheimer disease and Parkinson disease
Bioactive food compounds include ingredients with diverse effects in the human body, many of which display antioxidant activity and are linked to reduced inflammation